Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil

Eitemau Tebyg

• Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy
  gan: Chiarelli, Laurent R, et al.
  Cyhoeddwyd: (2010)
• Inosine 5’-Monophosphate Dehydrogenase 1 Haplotypes and Association with Mycophenolate Mofetil Gastrointestinal Intolerance in Pediatric Heart Transplant Patients
  gan: Ohmann, Erin L, et al.
  Cyhoeddwyd: (2010)
• Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8*2 variant allele
  gan: Woillard, Jean-Baptiste, et al.
  Cyhoeddwyd: (2010)
• A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients
  gan: Picard, Nicolas, et al.
  Cyhoeddwyd: (2006)
• The Application of Inosine 5′-Monophosphate Dehydrogenase Activity Determination in Peripheral Blood Mononuclear Cells for Monitoring Mycophenolate Mofetil Therapy in Children with Nephrotic Syndrome
  gan: Joanna Sobiak, et al.
  Cyhoeddwyd: (2020-08-01)